Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102766092A reveals a mild, high-enantioselective route to tetrahydroquinoline derivatives using chiral spiro phosphoric acid, offering significant cost reduction in API manufacturing.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105709826B reveals recyclable manganese catalyst for asymmetric sulfide oxidation, offering cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high enantioselectivity and potent anticancer activity.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Novel axial chiral bisindole catalyst synthesis offers high enantioselectivity and mild conditions for cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones using chiral phosphoric acid, offering cost-effective solutions for API manufacturing.
Patent CN113980028A reveals a mild organocatalytic route for chiral spiro indolones. Discover cost-effective manufacturing and high stereoselectivity for API intermediates.
Novel patent CN116655616B reveals efficient synthesis for chiral ligands enabling cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing processes.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering scalable solutions for reliable pharmaceutical intermediate suppliers.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.
Novel copper-catalyzed method for high-purity pharmaceutical intermediates. Reduces steps and enhances supply chain reliability for global buyers seeking scalable solutions.
Patent CN118878543A reveals high-purity axial chiral synthesis with significant PC-3 cytotoxic activity and scalable catalytic asymmetric methods for supply chain optimization.
Patent CN110467555B details a chiral phosphoric acid catalyzed method for high-purity axial chiral aryl indoles, offering cost-effective routes for oncology drug development.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole intermediates with superior purity and scalability.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN105294599B reveals a novel asymmetric synthesis for thiadiazine diuretics. Discover cost-effective catalytic methods and scalable supply chain solutions.
Patent CN105111228A reveals enhanced chiral phosphoric acid synthesis. Offers superior enantioselectivity and industrial scalability for pharmaceutical manufacturing.
Patent CN102040594A introduces a recyclable chiral bisoxazoline ligand with imidazolium salts, offering superior enantioselectivity and stability for pharmaceutical intermediate manufacturing.